[Ga68] DOTATATE PET/MRI-Guided Radiosurgical Treatment Planning and Response Assessment in Meningiomas.
Jana IvanidzeSe Jung ChangArsalan HaghdelJoon Tae KimArindam RoyChoudhuryAlan WuRohan R RamakrishnaTheodore H SchwartzBabacar CissePhilip StiegLeland MullerJoseph R OsborneRajiv S MaggeNicolas A KarakatsanisMichelle RoytmanEaton LinSusan C PannulloJoshua David PalmerJonathan P S KniselyPublished in: Neuro-oncology (2024)
DOTATATE PET SUV and SUVRSSS demonstrated marked, significant decrease post radiosurgery. Lesion size decrease was statistically significant, however it was not clinically significant by RANO criteria. DOTATATE PET/MR thus represents a promising imaging biomarker for response assessment in meningiomas treated with radiosurgery.